Acticor Biotech Aktie 114349796 / FR0014005OJ5
0.17
EUR
-0.11
EUR
-39.29%
10.12.2024
BMN
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
Acticor Biotech Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | Acticor Biotech | 0.00 | 0.00 | EUR |
| 2022 | Acticor Biotech | 0.00 | 0.00 | EUR |
| 2021 | Acticor Biotech | 0.00 | 0.00 | EUR |
| 2020 | Acticor Biotech | - | - | EUR |
| 2019 | Acticor Biotech | - | - | EUR |
Zu diesem Datensatz liegen uns leider keine Daten vor.
Acticor Biotech Termine
| Unternehmen | Event | Datum |
|---|
Acticor Biotech vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q2 2024 Earnings Release | 31.10.2024 |
| Hauptversammlung | Annual General Meeting | 25.10.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 09.07.2024 |
| Quartalszahlen | Q2 2023 Earnings Release | 26.10.2023 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Afer - Flore | 0.95 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 14 | 18 | 25 | 21 | 28 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Bilanz (in Mio. EUR) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 14 | 10 | 17 | 12 | 9 |
| Summe Anlagevermögen | 1 | 1 | 1 | 1 | 0 |
| Summe Aktiva | 15 | 11 | 18 | 13 | 10 |
Bilanz (in Mio. EUR) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 6 | 9 | 7 | 15 | 15 |
| Summe Eigenkapital | 9 | 2 | 11 | -2 | -5 |
| Summe Passiva | 15 | 11 | 18 | 13 | 10 |
Adresse
| Wojo Building, 75014 Paris | |
| Telefon | +33 (7) 76-23-38-13 |
| URL | http://www.acticor-biotech.com |
Management
|
Adeline Meilhoc
Head-Global Clinical Development |
|
Alain H. Munoz
Chairman |
|
Alain Parthoens
Director |
|
Andrea Comenducci
Senior Director-Medical |
|
Anouar Sari
Head-Clinical Operations |
|
Antoine Lebel
Communication Assistant |
|
Aymeric Humblot
Head-Finance & Administration |
|
Catherine Boule
Director |
|
Elsa Sirou
Senior Manager-Regulatory Affairs |
|
Francois Guillet
Chief Financial Officer |
|
Gilles Avenard
Chief Executive Officer & Director |
|
Guy Heynen
Director |
|
Hervé Bachelot Lallier
Director |
|
James Stearns
Observer |
|
Jean-Pierre Cazenave
Independent Director |
|
Jessica Jami
Manager-Regulatory Affairs |
|
Leila Nicolas
Director |
|
Patricia Zilliox
Independent Director |
|
Philippe Billiald
Scientific Founder |
|
Rinaldo del Bono
Director |
|
Sirine Bougamra
Medical Director |
|
Sophie Binay
General Manager & Chief Scientific Officer |
|
Yannick Plétan
Chief Medical Officer & General Manager |